Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

Delayed Data
As of Apr 03
 +0.29 / +3.57%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 12.00, with a high estimate of 16.00 and a low estimate of 7.00. The median estimate represents a +42.69% increase from the last price of 8.41.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.13%
Growthannually 1.81%


Growthquarterly -7.33%
Growthannually -0.74%
Key to the earnings and sales forecast charts.